MedAdvisor Limited announced resignation of RaeAnn Grossman as a Non-Executive Director on the Board of MedAdvisor, effective immediately. A new US-based Director nominated by Cotiviti Inc., will be appointed to support the continued expansion of MedAdvisor's global pharmacy network and further technological innovation to keep the Company at the forefront of digital medication management solutions in Australia, US, New Zealand and the UK.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.31 AUD | +1.64% | +5.08% | +44.19% |
Apr. 24 | MedAdvisor Operating Revenue Rises 42% to AU$24.2 Million in March Quarter | MT |
Apr. 23 | MedAdvisor's Gross Profit Climbs 48.5% in Fiscal Q3, Revenue Rises 42.4% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.19% | 113M | |
+5.70% | 32.88B | |
+18.46% | 7.84B | |
+22.71% | 3.95B | |
-17.95% | 3.11B | |
-19.93% | 1.38B | |
-30.65% | 1.21B | |
+4.36% | 933M | |
-34.81% | 911M | |
-26.60% | 829M |
- Stock Market
- Equities
- MDR Stock
- News MedAdvisor Limited
- Medadvisor Limited Announces Resignation of RaeAnn Grossman as Non-Executive Director